Cowen & Company Upgrades Eli Lilly and to Outperform

Home › Cowen & Company Upgrades Eli Lilly and to Outperform

The firm currently has a $68.00 price objective on the stock, up from their previous price objective of $61.00.

14.11	Take a closer look at replacement female market
14.11	Smithfield Foods responds to Minnesota Department of Labor and Industry settlement
14.11	Is anyone keeping heifers?
14.11	Cattle groups hail Thune as pick for Senate Majority Leader
14.11	McDonalds, Syngenta and Lopez Foods aim to increase feed efficiency, reduce GHG emissions
14.11	As holidays approach, ham demand, associated wholesale prices increasing
14.11	Farm Progress announces return of Clint Peck to BEEF
14.11	Contingency feed plans: Allows for wiggle room, ensures pigs stay healthy
Agriculture and Forestry »

je.st